Arcus Biosciences (RCUS) Other Working Capital Changes (2018 - 2026)

Arcus Biosciences' Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$16.0 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 42.86% year-over-year to -$16.0 million; the TTM figure through Mar 2026 stood at $20.0 million (down 48.72% YoY), while the FY2025 annual figure was $8.0 million, down 68.0% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$16.0 million, down from $222.0 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $6.3 million in Q3 2021, with the low at -$6.6 million in Q4 2021.
• The 5-year median for Other Working Capital Changes is $193000.0 (2019), against an average of -$106842.1.
• The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes slumped 2400.0% in 2023, then soared 880.0% in 2024.
• Arcus Biosciences' Other Working Capital Changes stood at $11.0 million in 2022, then plunged by 145.45% to -$5.0 million in 2023, then jumped by 880.0% to $39.0 million in 2024, then jumped by 469.23% to $222.0 million in 2025, then slumped by 107.21% to -$16.0 million in 2026.
• Business Quant data shows RCUS's Other Working Capital Changes at -$16.0 million in Q1 2026, $222.0 million in Q4 2025, and -$214.0 million in Q3 2025.